TY - JOUR
T1 - Recurrent leishmaniasis in kidney transplant recipients: Report of 2 cases and systematic review of the literature
AU - Cascio, Antonio
AU - Nilufer Broeders, null
AU - Simon, null
AU - Corbellino, Mario
AU - Wissing, null
AU - Del Marmol, null
AU - Remmelink, null
AU - Antinori, null
AU - Cascio, null
AU - Abramowicz, null
AU - Nortier, null
PY - 2011
Y1 - 2011
N2 - The characteristics of 8 episodes of leishmaniasis with atypical manifestations in 2 Italian kidney transplant recipients are analyzed and contextualized among those of 52 other episodes of leishmaniasis observed in 19 transplant recipients found through a systematic review of the international literature. In all the patients, the initial episode was visceral leishmaniasis, which was associated with mucocutaneous involvement in 2 cases. With the exception of 1 case of post kala-azar dermal leishmaniasis, 2 episodes of Leishmania endophthalmitis, and 3 episodes of mucocutaneous leishmaniasis, all the recurrences were characterized by visceral involvement. The potential role of polymerase chain reaction in monitoring the infection, the importance of a long follow-up, the potential benefit of chemoprophylaxis, and the therapeutic challenges are discussed. © 2011 John Wiley & Sons A/S.
AB - The characteristics of 8 episodes of leishmaniasis with atypical manifestations in 2 Italian kidney transplant recipients are analyzed and contextualized among those of 52 other episodes of leishmaniasis observed in 19 transplant recipients found through a systematic review of the international literature. In all the patients, the initial episode was visceral leishmaniasis, which was associated with mucocutaneous involvement in 2 cases. With the exception of 1 case of post kala-azar dermal leishmaniasis, 2 episodes of Leishmania endophthalmitis, and 3 episodes of mucocutaneous leishmaniasis, all the recurrences were characterized by visceral involvement. The potential role of polymerase chain reaction in monitoring the infection, the importance of a long follow-up, the potential benefit of chemoprophylaxis, and the therapeutic challenges are discussed. © 2011 John Wiley & Sons A/S.
UR - http://hdl.handle.net/10447/160432
M3 - Article
SN - 1398-2273
VL - 13
SP - 397
EP - 406
JO - Transplant Infectious Disease
JF - Transplant Infectious Disease
ER -